Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study
- 11 August 2009
- Vol. 27 (43) , 5936-5941
- https://doi.org/10.1016/j.vaccine.2009.07.098
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- G2 Strain of Rotavirus among Infants and Children, BangladeshEmerging Infectious Diseases, 2009
- Rotavirus Genotype Distribution after Vaccine Introduction, Rio de Janeiro, BrazilEmerging Infectious Diseases, 2009
- Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III studyThe Lancet, 2008
- A short report on highlights of worldwide development of RIX4414: A Singaporean experienceVaccine, 2006
- The paediatric burden of rotavirus disease in EuropeEpidemiology and Infection, 2006
- Sentinel Hospital Surveillance for Rotavirus Diarrhea in Taiwan, 2001–2003The Journal of Infectious Diseases, 2005
- Hospital‐Based Study of the Economic Burden Associated with Rotavirus Diarrhea in Hong KongThe Journal of Infectious Diseases, 2005
- Estimates of Rotavirus Disease Burden in Hong Kong: Hospital‐Based SurveillanceThe Journal of Infectious Diseases, 2005
- Comment on: Confidence limits for the ratio of two rates based on likelihood scores: non-iterative methodStatistics in Medicine, 2004
- Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal EpisodesScandinavian Journal of Infectious Diseases, 1990